NASDAQ:CGEM
Cullinan Oncology
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.cullinanoncology.comcrunchbase
cullinan-oncologylinkedin
cullinan-oncologyfounding date
Jan 01, 2017ipo date
Jan 08, 2021
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its p...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus